News headlines about DaVita HealthCare Partners (NYSE:DVA) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. DaVita HealthCare Partners earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.3500203505479 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
These are some of the news headlines that may have effected Accern’s analysis:
- DaVita Issues Downbeat ’17 View, Hurricanes Affect Q3 Results – Nasdaq (nasdaq.com)
- DaVita Issues Downbeat '17 View, Hurricanes Affect Q3 Results (finance.yahoo.com)
- DaVita HealthCare Partners Inc. Expected to Earn FY2017 Earnings of $3.42 Per Share (DVA) (americanbankingnews.com)
- Contrasting Fresenius Medical Care Corporation (FMS) & DaVita HealthCare Partners (DVA) (americanbankingnews.com)
- DaVita HealthCare Partners Inc. (DVA) Given “Hold” Rating at Robert W. Baird (americanbankingnews.com)
A number of research firms recently weighed in on DVA. KeyCorp restated a “hold” rating on shares of DaVita HealthCare Partners in a research note on Monday. Robert W. Baird restated a “hold” rating and set a $63.00 target price on shares of DaVita HealthCare Partners in a research note on Friday, November 10th. Bank of America Corporation lowered their target price on shares of DaVita HealthCare Partners from $75.00 to $66.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 8th. Royal Bank Of Canada lowered their target price on shares of DaVita HealthCare Partners from $64.00 to $60.00 and set a “sector perform” rating on the stock in a research note on Wednesday, November 8th. Finally, Wolfe Research upgraded shares of DaVita HealthCare Partners from a “market perform” rating to an “outperform” rating in a research note on Monday, October 23rd. Four equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $63.00.
DaVita HealthCare Partners (NYSE:DVA) last announced its quarterly earnings results on Tuesday, November 7th. The company reported $0.81 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.13). The company had revenue of $3.92 billion during the quarter, compared to the consensus estimate of $3.91 billion. DaVita HealthCare Partners had a net margin of 3.40% and a return on equity of 13.31%. The business’s revenue was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.95 earnings per share. equities analysts anticipate that DaVita HealthCare Partners will post 3.42 earnings per share for the current fiscal year.
DaVita HealthCare Partners announced that its Board of Directors has initiated a share repurchase plan on Tuesday, October 10th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.
WARNING: “DaVita HealthCare Partners (DVA) Receiving Somewhat Positive News Coverage, Report Shows” was originally reported by Markets Daily and is the property of of Markets Daily. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.themarketsdaily.com/2017/11/16/davita-healthcare-partners-dva-receiving-somewhat-positive-news-coverage-report-shows.html.
About DaVita HealthCare Partners
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.